Back to Trades
ADAR1 Capital Management, LLC
10% OwnerCIK 0001940272
Total Volume
$107.2M
17 filings
Purchases
$11.6M
41 buy txns
Sales
$95.7M
3 sell txns
Net Activity
-$84.1M
net sold
Profile
- Filings
- 17
- Buy transactions
- 41
- Sell transactions
- 3
- Companies
- 5
- Active
- 2025–2026
Across 17 filings between 2025–2026, ADAR1 Capital Management, LLC, 10% Owner, has disclosed $107.2M in transactions — spread across 5 companies. Their disclosed trades are heavily weighted toward selling — $11.6M in buys and $95.7M in sells. The largest single open-market purchase on record is $2.2M in Rallybio Corp. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
17 loaded
| Sep 16 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $118.1K |
| Sep 8 | TENX TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.6M |
| Sep 2 | TENX TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.4M |
| Aug 24 | TENX TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.8M |
| Aug 24 | TENX TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% Owner | Other | $0 |
| Aug 3 | NXTC NextCure, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.6M |
| Jul 29 | NXTC NextCure, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $87.7K |
| Jul 29 | NXTC NextCure, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Other | $0 |
| Jul 17 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.6K |
| May 21 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Buy | $721.5K |
| May 21 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Other | $0 |
| May 20 | RLYB Rallybio Corp | ADAR1 Capital Management, LLC | 10% Owner | Buy | $226.6K |
| May 15 | RLYB Rallybio Corp | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.1M |
| May 13 | RLYB Rallybio Corp | ADAR1 Capital Management, LLC | 10% Owner | Buy | $711.1K |
| May 6 | RLYB Rallybio Corp | ADAR1 Capital Management, LLC | 10% Owner | Buy | $2.2M |
| May 6 | RLYB Rallybio Corp | ADAR1 Capital Management, LLC | 10% Owner | Other | $0 |
| Oct 15 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Sell | $95.7M |
17 filings